FARSB, phenylalanyl-tRNA synthetase subunit beta, 10056
N. diseases: 53; N. variants: 10
Source: ALL
Disease | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.420 | GeneticVariation | group | BEFREE | Homozygosity for FARSB mutation leads to Phe-tRNA synthetase-related disease of growth restriction, brain calcification, and interstitial lung disease. | 30014610 | 2018 | ||||
|
0.420 | Biomarker | group | BEFREE | Recently, biallelic FARSB defects have been shown to cause severe growth restriction with combined brain, liver and lung involvement (Rajab interstitial lung disease [ILD] with brain calcifications). | 31355908 | 2019 | ||||
|
0.010 | GeneticVariation | disease | BEFREE | <b>Rationale:</b> Pulmonary alveolar proteinosis (PAP) is characterized by filling of the alveolar spaces by lipoprotein-rich material of ill-defined composition, and is caused by molecularly different and often rare diseases that occur from birth to old age.<b>Objectives:</b> To perform a quantitative lipidomic analysis of lipids and the surfactant proteins A, B, and C in lavage fluids from patients with proteinosis of different causes in comparison with healthy control subjects.<b>Methods:</b> During the last two decades, we have collected BAL samples from patients with PAP due to autoantibodies against granulocyte-macrophage colony-stimulating factor; genetic mutations in CSF2RA (colony-stimulating factor 2 receptor α-subunit), MARS (methionyl aminoacyl-tRNA synthetase), FARSB (phenylalanine-tRNA synthetase, β-subunit), and NPC2 (Niemann-Pick disease type C2); and secondary to myeloid leukemia. | 31002528 | 2019 | ||||
|
0.700 | CausalMutation | disease | CLINVAR | |||||||
|
0.700 | GeneticVariation | disease | CLINVAR | |||||||
|
0.400 | CausalMutation | phenotype | CLINVAR | |||||||
|
0.100 | CausalMutation | disease | CLINVAR | |||||||
|
0.100 | CausalMutation | disease | CLINVAR | |||||||
|
0.100 | CausalMutation | phenotype | CLINVAR | |||||||
|
0.100 | CausalMutation | disease | CLINVAR | |||||||
|
0.100 | CausalMutation | disease | CLINVAR | |||||||
|
0.100 | CausalMutation | phenotype | CLINVAR | |||||||
|
0.100 | CausalMutation | phenotype | CLINVAR | |||||||
|
0.100 | GeneticVariation | disease | CLINVAR | |||||||
|
0.700 | Biomarker | disease | CTD_human | |||||||
|
0.420 | Biomarker | group | HPO | |||||||
|
0.400 | Biomarker | disease | HPO | |||||||
|
0.400 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | disease | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | disease | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | disease | HPO | |||||||
|
0.100 | Biomarker | phenotype | HPO | |||||||
|
0.100 | Biomarker | disease | HPO |